University of Illinois-Chicago Research: Cancer Drug That Treats Herpes, Too
March 25, 2026
March 25, 2026
CHICAGO, Illinois, March 25 (TNSjou) -- The University of Illinois Chicago campus issued the following news release:
* * *
UIC research: A cancer drug that treats herpes, too
UIC researchers have successfully repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of herpes. Their work appears in the journal Drug Resistance Updates.
"This opens up an unexpected, potentially fast-moving path toward treating drug . . .
* * *
UIC research: A cancer drug that treats herpes, too
UIC researchers have successfully repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of herpes. Their work appears in the journal Drug Resistance Updates.
"This opens up an unexpected, potentially fast-moving path toward treating drug . . .